Five years after the start of the pandemic, the fight over who owns the underlying technologies that made the Covid-19 ...
A German court found Wednesday that American pharmaceutical giant Pfizer and German firm BioNTech violated a patent to make ...
Five years ago, on March 11, the World Health Organization declared COVID-19 a global pandemic. The vaccines “underwent the most intensive safety analysis in U.S. history." ...
Pfizer and BioNTech won a round in their legal battle with Moderna over COVID-19 vaccine patents on Wednesday, convincing a U ...
The Düsseldorf Regional Court has ordered Pfizer and its German partner BioNTech to pay damages for the use of Moderna’s ...
The National Institutes of Health is terminating dozens of studies examining why people are hesitant about vaccines and how ...
Patent Trial and Appeal Board (PTAB) docket entries indicate that the PTAB has invalidated all challenged claims of Moderna’s ...
3d
Stocktwits on MSNBioNTech's 2025 Revenue View, Vaccine Policy Uncertainty Prompt Price-Target Cut: Retail Stays Cautiously OptimisticU.S.-listed shares of BioNTech SE ended Monday nearly 3.2% lower, weighed down by a weak full-year revenue projection even as ...
BioNTech SE exceeded earnings expectations with strong oncology pipeline development, despite reduced vaccine revenue.
German COVID-19 vaccine maker BioNTech on Monday said that its 2025 revenues would likely fall to between 1.7 billion euros ...
German biotech firm's revenues down 27% compared to 2023, according to company's financial report - Anadolu Ajansı ...
Reuters on MSN8d
Pfizer and BioNTech violated COVID-19 vaccine patent held by Moderna, German court rulesThe court said Pfizer and BioNTech would have to provide information on earnings derived from the use of the patent and that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results